A new credit card-sized device has been developed to help physicians to monitor heart disease from only 200 microliters of blood. The device works similar to Velcro that only binds to endothelial progenitor cells
A SPECK of blood would soon be enough to test patients at risk of heart troubles, according to a research report of Northeastern University in Boston.
A new credit card-sized device has been developed to help physicians to monitor heart disease from only 200 microliters of blood.
Dr Shashi K Murthy and associates have shown that the device can measure and collect a type of cells needed to build vascular tissue. The device works similar to Velcro that only binds to endothelial progenitor cells. The device could become a versatile tool to assess cardiovascular health with the amount of blood as much as a pin prick. "This simple device is a promising tool for the pediatric and adult population in detecting, diagnosing, monitoring and providing the option of treating cardiovascular disease by utilising a small quantity of blood," said Dr Murthy.